U.S. market Closed. Opens in 2 hours 48 minutes

RGC | Regencell Bioscience Holdings Limited Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-302017-12-312016-12-312015-12-312015-01-012013-12-262012-12-272011-12-292010-12-302009-12-312009-01-012007-12-272006-12-282005-12-292004-12-302004-01-012002-12-26
RevenueN/AN/AN/AN/AN/A3.16B3.20B3.13B2.99B3.04B2.82B2.68B2.81B2.89B2.77B2.66B2.60B2.52B2.47B2.49B2.14B
Cost of Revenue769.69K604.40K26.46K9.52KN/A123.00M1.23B1.21B111.00M111.00M101.00M96.00M101.00M1.16B106.00M103.00M104.00M96.00M94.00M92.00M84.00M
Gross Profit-769.69K-604.40K-26.46K-9.52KN/A3.04B1.97B1.92B2.88B2.93B2.72B2.59B2.71B1.74B2.67B2.56B2.49B2.42B2.37B2.40B2.06B
Operating Expenses6.27M7.62M1.38M812.37K390.99K1.31B1.63B1.58B1.19B1.16B1.05B1.04B1.23B1.42B2.49B2.34B2.29B2.25B2.15B2.11B1.86B
Selling, General & Admin4.69M5.11M943.04K426.14K162.77K86.60M512.20M500.30M74.40M73.70M68.80M65.80M66.70M443.00M62.00M63.00M65.00M61.00M63.00M62.00M65.00M
Research & Development1.58M2.51M438.32K386.23K228.22KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses211.34K23.21K34.62KN/AN/A1.22B1.11B1.08B1.12B1.09B985.30M976.20M1.17B980.40M2.42B2.28B2.22B2.19B2.08B2.05B1.79B
Operating Income-6.27M-7.62M-1.38M-812.37K-390.99K271.70M344.20M339.00M306.40M339.80M334.20M221.30M215.80M313.40M284.00M322.00M308.00M269.00M321.00M379.00M283.00M
Other Expenses / Income211.34K23.21K34.62K-1.00N/A-57.80M-62.50M-85.70M-127.80M-75.20M-98.30M-163.50M-140.10M-156.20M-161.00M283.00M-164.00M-117.00M-179.00M-73.00M-75.00M
Before Tax Income-6.06M-7.59M-1.35M-812.37K-390.99K213.90M281.70M253.30M178.60M264.60M235.90M57.80M75.70M157.20M123.00M605.00M144.00M152.00M142.00M306.00M208.00M
Income Tax Expenses-191.20K-171.83K-210.10K-1.00-390.00101.60M111.20M100.10M73.40M107.00M91.20M17.70M48.70M61.90M50.00M242.00M57.00M60.00M59.00M121.00M89.00M
Net Income-5.87M-7.42M-1.35M-812.37K-390.99K112.30M170.40M153.40M105.60M157.70M144.80M40.30M77.60M95.50M72.00M363.00M86.00M91.00M82.00M185.00M117.00M
Interest ExpensesN/A-23.21KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A152.80M-124.00M-112.00M-125.00M-117.00M-95.00M-72.00M61.00M
Basic Shares Outstanding13.01M13.01M12.64M12.64M12.64M156.34M156.79M156.45M155.29M154.83M154.17M153.58M153.40M153.05M1.16M5.75M1.31M144.44M143.86M138.06M140.96M
Diluted Shares Outstanding13.01M13.01M12.64M12.64M12.64M156.99M156.80M156.50M156.31M155.72M154.99M154.56M154.52M154.10M1.16M5.75M1.31M154.24M149.09M142.31M148.10M
EBITDA-5.50M-7.01M-1.35M-802.86K-390.99K468.70M512.30M470.30M391.00M469.20M422.20M259.70M352.50M512.10M200.00M676.00M215.00M233.00M220.00M392.00M401.00M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%14.82%16.02%15.04%13.08%15.44%14.95%9.68%12.55%17.70%7.22%25.40%8.28%9.26%8.91%15.75%18.74%
EBIT-6.06M-7.62M-1.56M-812.37K-391.38K213.90M281.60M253.50M179.00M264.70M236.00M58.00M126.30M310.20M-2.00M493.00M18.00M34.00M46.00M234.00M267.00M
EBIT Margin0.00%0.00%0.00%0.00%0.00%6.76%8.81%8.11%5.99%8.71%8.36%2.16%4.50%10.72%-0.07%18.53%0.69%1.35%1.86%9.40%12.48%
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-302017-12-312016-12-312015-12-312015-01-012013-12-262012-12-272011-12-292010-12-302009-12-312009-01-012007-12-272006-12-282005-12-292004-12-302004-01-012002-12-26
An error has occurred. This application may no longer respond until reloaded. Reload 🗙